comparemela.com

Latest Breaking News On - Child level menu hover - Page 2 : comparemela.com

SRI, Amylyx Pharmaceuticals partner to identify ALS drug candidates

SRI and Amylyx have joined forces to develop new drug candidates to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Menu-hover
Subchild-level-menu-hover
Child-level-menu-hover
End-third-level
Bend-article
End-timeline

Mogrify, Astellas Pharma partner for sensorineural hearing loss treatment

Mogrify has collaborated with Astellas Pharma to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss.

Menu-hover
Subchild-level-menu-hover
Child-level-menu-hover
End-third-level
Bend-article
End-timeline

ViGeneron signs collaboration agreement with Regeneron Pharmaceuticals

ViGeneron, a Germany-based gene therapy company, has entered a target-specific strategic collaboration and option agreement with Regeneron Pharmaceuticals.

Germany
Regeneron-pharmaceuticals
Menu-hover
Subchild-level-menu-hover
Child-level-menu-hover
End-third-level
Bend-article
End-timeline

Bristol Myers Squibb gets FDA approval for metastatic melanoma therapy

Bristol Myers Squibb has obtained approval from the US FDA for Opdualag to treat unresectable or metastatic melanoma patients.

Bristol-myers-squibb-opdualag
Samit-hirawat
Drug-administration
Bristol-myers-squibb
Bristol-myers-squibb-company
Myers-squibb
Menu-hover
Subchild-level-menu-hover
Child-level-menu-hover

Sanofi, Blackstone partner to advance multiple myeloma treatment

Sanofi has announced a collaboration with investment management firm Blackstone to advance an innovative treatment for multiple myeloma.

Menu-hover
Subchild-level-menu-hover
Child-level-menu-hover
End-third-level

vimarsana © 2020. All Rights Reserved.